Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
ADXS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: May 21, 2024
Report Source: 2023 Annual Report
Ayala Pharmaceuticals Inc. Stock Analysis ADXS
United States Health Care Nano Cap Report: Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. The company is headquartered in Monmouth Junction, New Jersey and currently employs 20 full-time employees. The company went IPO on 2005-07-28. The firm's lead candidate is aspacytarabine (BST-236), a novel anti-metabolite for first line treatment in unfit acute myeloid leukemia (AML). Aspacytarabine (BST-236) is composed of cytarabine covalently bound to asparagine, acting as a pro-drug of cytarabine.
Read More Ayala Pharmaceuticals Inc (ADXS) Chart
Key Statistics of Ayala Pharmaceuticals Inc (ADXS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.60Volume
13.59KP/E Ratio (TTM)
-52 Week Range
Market Cap
24.30MAvg. Volume
17.86KDividend Yield
-Financial Metrics & Statements of Ayala Pharmaceuticals Inc (ADXS)
FAQ's for Ayala Pharmaceuticals Inc (ADXS)
- According to Musaffa’s Shariah screening methodology, Ayala Pharmaceuticals Inc (ADXS) is currently classified as NOT HALAL as of May 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ayala Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Ayala Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Ayala Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Ayala Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Ayala Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.